EUVIMEDEUVIMED entdecken
Crossref

β-Hydroxybutyrate Exerts Anti-Tumor Effects in Nasopharyngeal Carcinoma Through Caspase-3-Mediated Apoptosis

Zihui Rong, Wanqi Wei, Shiyue Tang, Yunliang Lu, Xiaoying Zhou, Xue Xiao, Jinfeng Liang, Weilin Zhao, Zhe Zhang

ENT Discovery · 2026

DOI: 10.15302/entd.2026.090004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ENT Discovery, 2026. Verfasst von Zihui Rong und 8 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ketogenic enzymes are downregulated and act as tumor suppressors in nasopharyngeal carcinoma (NPC), yet the antitumor mechanisms of the ketone body β-hydroxybutyrate (β-HB) in NPC remain unclear.

Methods

Network pharmacology, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, and molecular docking were used to identify candidate β-HB–NPC targets. In vitro, the effects of β-HB on cell viability, colony formation, caspase-3 enzymatic activity, and apoptosis were assessed in NPC cells. Dose- and time-response cell viability analyses were also performed using NP69 cells. Caspase-3 involvement was evaluated using Z-DEVD-FMK and CASP3 siRNA. Two independent NPC C17 patient-derived xenograft (PDX) experiments used alternate-day fasting or a ketogenic diet to induce ketosis. Epstein–Barr virus (EBV) lytic-gene expression, EBV DNA copy number, and tumor EBV-encoded RNAs (EBER) status were also assessed.

Results

We identified 177 overlapping β-HB–NPC targets and five hub targets, with caspase-3 prioritized as an apoptosis-associated functional node. Molecular docking predicted a compatible binding pose for β-HB within caspase-3, but did not establish direct binding. In vitro, β-HB suppressed cell viability and clonogenic growth without reducing NP69 viability under the tested conditions. It increased caspase-3 activity, cleaved caspase-3, PARP-1, and promoted apoptosis. Both Z-DEVD-FMK and CASP3 silencing attenuated β-HB-induced apoptosis. In vivo, both independent PDX experiments demonstrated tumor suppression accompanied by elevated ketone-related measures. Tumors from both intervention groups exhibited reduced Ki-67 expression, and increased terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) positivity. β-HB also upregulated the EBV immediate-early lytic gene expression (BZLF1 and BRLF1), while a nonsignificant trend toward increased EBER positivity was observed in fasting-treated tumors.Conclusion: β-HB suppresses NPC cell growth and promotes apoptosis, with caspase-3 serving as a functional mediator. In vivo, both dietary interventions suppressed tumor growth and were accompanied by increases in ketone-related measures. β-HB also induces EBV immediate-early lytic gene expression, supporting further investigation of ketone metabolism as a potential therapeutic strategy for NPC.

Zitieren

APA

Rong, Z., Wei, W., Tang, S., Lu, Y., Zhou, X., Xiao, X., Liang, J., Zhao, W., & Zhang, Z. (2026). β-Hydroxybutyrate Exerts Anti-Tumor Effects in Nasopharyngeal Carcinoma Through Caspase-3-Mediated Apoptosis. ENT Discovery. https://doi.org/10.15302/entd.2026.090004

Vancouver

Rong Z, Wei W, Tang S, Lu Y, Zhou X, Xiao X, et al. β-Hydroxybutyrate Exerts Anti-Tumor Effects in Nasopharyngeal Carcinoma Through Caspase-3-Mediated Apoptosis. ENT Discovery. 2026. doi:10.15302/entd.2026.090004

BibTeX
@article{Rong2026,
  author = {Rong, Zihui and Wei, Wanqi and Tang, Shiyue and Lu, Yunliang and Zhou, Xiaoying and Xiao, Xue and Liang, Jinfeng and Zhao, Weilin and Zhang, Zhe},
  title = {β-Hydroxybutyrate Exerts Anti-Tumor Effects in Nasopharyngeal Carcinoma Through Caspase-3-Mediated Apoptosis},
  journal = {ENT Discovery},
  year = {2026},
  doi = {10.15302/entd.2026.090004}
}
Kostenlos starten →